Phytohemagglutinin (PHA) (6.25 µg/mL) for positive control or medium alone for negative control. They were then cultured at 37°C with 5 % CO2. Supernatants were harvested after four days of stimulation, frozen and later assayed for IFN-γ by ELISA according to the manufacturer's recommendations (Pelikin Compact; CLB). Optical density was determined using an automated MR5000 ELISA reader (Thermolab Systems), and the final results were standardized per million PBMC's, in the unit pg/mL/10 6 PBMC's.
with a linear regression for risk factors selected from those recorded in the French sample during recruitment. The selected covariates were chosen to be significantly associated with at least one of the three studied phenotypes in univariate analysis and to give the best fit in terms of the Akaike's information criterion (AIC) in the multivariate final model.
Relevant covariates for these analyses included the annual incidence of TB in the country of birth (in two categories, more or less than 100 new TB cases per 100,000 per year), the estimated total exposure to the index case quantified as the log(number of contact hours with index case during the three months preceding the TB diagnosis), the infectivity of the index case defined as the presence of cavitation on chest radiography and the presence of bacilli in sputum smears, the complementary health insurance cover (yes/no), and age. Regarding IFNγ-BCG and IFNγ-PPD phenotypes, the effect of the index case infectivity was dependent on age, and an interaction term between infectivity and age was added in the regression model. As the majority of individuals were BCG vaccinated (89%), the BCG vaccine was not associated with any of the studied phenotype. We also investigated the effect of the timeframe between TST and blood sampling , which may introduce a potential boosting effect on IFN-γ production [3, 4] . As already shown [3, 5] , we confirmed that our mean phenotypes were not significantly different between individuals sampled within the three days following the TST (35% of participants), and individuals sampled before TST (32% of participants). We also found that the mean phenotypes of individuals sampled later than three days after TST (33% of participants) did not differ significantly according to their time of sampling. Therefore, we used a binary indicator of the time between TST administration and blood sampling, and found a higher IFN-γ production in subjects sampled three days after TST for IFNγ-BCG phenotype, and to a lesser extent for IFNγ-PPD and IFNγ-ESAT6 (Table S1 ). These three phenotypes were subsequently adjusted for sampling time and the other covariates for further analyses. The sampling time was not associated with the IFNγ-ESAT6BCG phenotype as expected by the adjustment for IFNγ-BCG. 
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